tradingkey.logo
tradingkey.logo
Pesquisar

AngioDynamics Inc

ANGO
Adicionar à lista de desejos
13.090USD
+0.010+0.08%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
545.62MValor de mercado
PerdaP/L TTM

Mais detalhes de AngioDynamics Inc Empresa

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

Informações de AngioDynamics Inc

Código da empresaANGO
Nome da EmpresaAngioDynamics Inc
Data de listagemMay 27, 2004
CEOClemmer (James C)
Número de funcionários675
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 27
Endereço14 Plaza Drive
CidadeLATHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal12110
Telefone15187981215
Sitehttps://www.angiodynamics.com/
Código da empresaANGO
Data de listagemMay 27, 2004
CEOClemmer (James C)

Executivos da empresa AngioDynamics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-35.34%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Chad T. Campbell
Mr. Chad T. Campbell
Senior Vice President, General Manager - Global Oncology and Vascular Access
Senior Vice President, General Manager - Global Oncology and Vascular Access
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-35.34%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de AngioDynamics Inc?

Os cinco principais acionistas de AngioDynamics Inc são: Mr. Stephen A. Trowbridge, J.D.

Quantas instituições possuem ações da AngioDynamics Inc (ANGO)?

Em 2026Q1, 321 instituições possuíam ações da AngioDynamics Inc, com valor de mercado aproximado de 38.82M, representando 93.94% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -7218201.00.